Table 3.

Biochemical analysis of the participants at the pre and post experimental period moments.

	MT (n = 52)			MFT (n = 43)			CG (n = 47)
	Pre	Post	Effect Size	Pre	Post	Effect Size	Pre	Post	Effect Size
Uric acid (mg/dL)	3.9 ± 1.5	3.6 ± 1.2	0.220	4.4 ± 1.5	3.7 ± 1.3	0.498	4.3 ± 1.6	4.8 ± 2.0	0.276
Glucose (mg/dL)	105.4 ± 28.7	100.6 ± 20.1b	0.193	106.7 ± 26.6	95.9 ± 17.0b,d	0.483	100.9 ± 23.1	103.7 ± 26.2b,c,d	0.113
Total Cholesterol (mg/dL)	179.3 ± 37.1	175.4 ± 39.2b	0.102	211.4 ± 53.4	205.4 ± 44.7b,d	0.121	195.7 ± 50.3	201.6 ± 47.6b,c,d	0.120
Triglycerides (mg/dL)	117.7 ± 57.5	118.4 ± 48.2b	0.0131	142.6 ± 60.4	130.6 ± 69.6b,d	0.184	122.4 ± 57.4	137.4 ± 81.7b,c	0.212
HDL Cholesterol (mg/dL)	50.3 ± 13.8	49.2 ± 15.0b	0.076	57.2 ± 15.7	52.7 ± 17.5b,d	0.270	49.8 ± 16.5	53.5 ± 16.2b,c	0.226
LDL Cholesterol (mg/dL)	105.5 ± 33.5	102.5 ± 37.2b	0.084	125.6 ± 48.4	122.7 ± 42.9b,d	0.063	119.5 ± 48.4	122.1 ± 44.3b,c,d	0.056

MT, multicomponent training; MFT, multicomponent and flexibility training; CG, control group. Bold: effect size ≥ 0.50.

^aTime effect (p < 0.05).

^bp < 0.05 in relation to the pre-intervention moment in the same group.

^cp < 0.05 in relation to the MFT at the same moment.

^dp < 0.05 in relation to the MT at the same moment.